| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
0.62 µM |
Be(2)-c |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
1.25 µM |
Be(2)-c |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
2.50 µM |
Be(2)-c |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
5.00 µM |
Be(2)-c |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
10.00 µM |
Be(2)-c |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
0.62 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
1.25 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
2.50 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
5.00 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
10.00 µM |
SMS-KCNR |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
0.62 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
1.25 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
2.50 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
5.00 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
10.00 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
0.62 µM |
IMR-32 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
1.25 µM |
IMR-32 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
2.50 µM |
IMR-32 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
5.00 µM |
IMR-32 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
10.00 µM |
IMR-32 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
0.62 µM |
LAN-5 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
1.25 µM |
LAN-5 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
2.50 µM |
LAN-5 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
5.00 µM |
LAN-5 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
10.00 µM |
LAN-5 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
0.62 µM |
MM1.RL |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
1.25 µM |
MM1.RL |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
2.50 µM |
MM1.RL |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
5.00 µM |
MM1.RL |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
10.00 µM |
MM1.RL |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
0.62 µM |
U266 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
1.25 µM |
U266 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
2.50 µM |
U266 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
5.00 µM |
U266 |
Homo sapiens |
|
|
|
| Withaferin A |
Influence on cell viability |
Staining with TOTO-3 Iodide |
10.00 µM |
U266 |
Homo sapiens |
|
|
|
